Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson’s Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study

Figure 1

Change from baseline in Parkinson’s Disease Sleep Scale (PDSS) sleep maintenance subscale score after 3 months of rotigotine treatment.